BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23637941)

  • 1. Emerging role of angiotensin type 2 receptor (AT2R)/Akt/NO pathway in vascular smooth muscle cell in the hyperthyroidism.
    Carrillo-Sepúlveda MA; Ceravolo GS; Furstenau CR; Monteiro Pde S; Bruno-Fortes Z; Carvalho MH; Laurindo FR; Tostes RC; Webb RC; Barreto-Chaves ML
    PLoS One; 2013; 8(4):e61982. PubMed ID: 23637941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid hormone stimulates NO production via activation of the PI3K/Akt pathway in vascular myocytes.
    Carrillo-Sepúlveda MA; Ceravolo GS; Fortes ZB; Carvalho MH; Tostes RC; Laurindo FR; Webb RC; Barreto-Chaves ML
    Cardiovasc Res; 2010 Feb; 85(3):560-70. PubMed ID: 19734167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fast relaxation and desensitization of angiotensin II contraction in the pulmonary artery via AT1R and Akt-mediated phosphorylation of muscular eNOS.
    Kim HJ; Jang JH; Zhang YH; Yoo HY; Kim SJ
    Pflugers Arch; 2019 Oct; 471(10):1317-1330. PubMed ID: 31468138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative regulation of RhoA/Rho kinase by angiotensin II type 2 receptor in vascular smooth muscle cells: role in angiotensin II-induced vasodilation in stroke-prone spontaneously hypertensive rats.
    Savoia C; Tabet F; Yao G; Schiffrin EL; Touyz RM
    J Hypertens; 2005 May; 23(5):1037-45. PubMed ID: 15834290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triiodothyronine Potentiates Vasorelaxation via PKG/VASP Signaling in Vascular Smooth Muscle Cells.
    Samuel S; Zhang K; Tang YD; Gerdes AM; Carrillo-Sepulveda MA
    Cell Physiol Biochem; 2017; 41(5):1894-1904. PubMed ID: 28376489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis in cystic medial degeneration associated with Marfan's syndrome.
    Nagashima H; Sakomura Y; Aoka Y; Uto K; Kameyama Ki ; Ogawa M; Aomi S; Koyanagi H; Ishizuka N; Naruse M; Kawana M; Kasanuki H
    Circulation; 2001 Sep; 104(12 Suppl 1):I282-7. PubMed ID: 11568070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasculoprotective effects of rosiglitazone through modulating renin-angiotensin system in vivo and vitro.
    Ren L; Liu N; Zhi H; Li Y; Li Y; Tang R; Sheng Z
    Cardiovasc Diabetol; 2011 Jan; 10():10. PubMed ID: 21269478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased vascular angiotensin type 2 receptor expression and NOS-mediated mechanisms of vascular relaxation in pregnant rats.
    Stennett AK; Qiao X; Falone AE; Koledova VV; Khalil RA
    Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H745-55. PubMed ID: 19151255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testosterone downregulates angiotensin II type-2 receptor via androgen receptor-mediated ERK1/2 MAP kinase pathway in rat aorta.
    Mishra JS; Hankins GD; Kumar S
    J Renin Angiotensin Aldosterone Syst; 2016 Oct; 17(4):. PubMed ID: 27765882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibitory effect of leptin on angiotensin II-induced vasoconstriction in vascular smooth muscle cells is mediated via a nitric oxide-dependent mechanism.
    Rodríguez A; Fortuño A; Gómez-Ambrosi J; Zalba G; Díez J; Frühbeck G
    Endocrinology; 2007 Jan; 148(1):324-31. PubMed ID: 17038553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of AT2 receptor and iNOS impairs angiotensin II-induced contraction without endothelium influence in young normotensive diabetic rats.
    Lee JH; Xia S; Ragolia L
    Am J Physiol Regul Integr Comp Physiol; 2008 Jul; 295(1):R144-54. PubMed ID: 18463192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired peroxisome proliferator-activated receptor-gamma contributes to phenotypic modulation of vascular smooth muscle cells during hypertension.
    Zhang L; Xie P; Wang J; Yang Q; Fang C; Zhou S; Li J
    J Biol Chem; 2010 Apr; 285(18):13666-77. PubMed ID: 20212046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
    Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M
    Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conditional expression of type 2 angiotensin II receptor in rat vascular smooth muscle cells reveals the interplay of the angiotensin system in matrix metalloproteinase 2 expression and vascular remodeling.
    Jing T; Wang H; Srivenugopal KS; He G; Liu J; Miao L; He Y
    Int J Mol Med; 2009 Jul; 24(1):103-10. PubMed ID: 19513542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paradoxical role of angiotensin II type 2 receptors in resistance arteries of old rats.
    Pinaud F; Bocquet A; Dumont O; Retailleau K; Baufreton C; Andriantsitohaina R; Loufrani L; Henrion D
    Hypertension; 2007 Jul; 50(1):96-102. PubMed ID: 17485601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Connexin37-Dependent Mechanisms Selectively Contribute to Modulate Angiotensin II -Mediated Hypertension.
    Le Gal L; Pellegrin M; Santoro T; Mazzolai L; Kurtz A; Meda P; Wagner C; Haefliger JA
    J Am Heart Assoc; 2019 Apr; 8(8):e010823. PubMed ID: 30943815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II type 2 receptor (AT2R) is associated with increased tolerance of the hyperthyroid heart to ischemia-reperfusion.
    Tavares FM; da Silva IB; Gomes DA; Barreto-Chaves ML
    Cardiovasc Drugs Ther; 2013 Oct; 27(5):393-402. PubMed ID: 23807455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of PKC-dependent extracellular Ca2+ entry contributes to the depression of contractile activity in long-term pressure-overloaded endothelium-denuded rat aortas.
    Padilla J; López RM; López P; Castillo MC; Querejeta E; Ruiz A; Castillo EF
    Braz J Med Biol Res; 2014 Sep; 47(9):789-98. PubMed ID: 25098618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of AMPK/proteasome/MLCK degradation signaling axis by telmisartan inhibits VSMC contractility and vessel contraction.
    Hwang YJ; Cho DH
    Biochem Biophys Res Commun; 2020 Apr; 524(4):853-860. PubMed ID: 32046856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects induced by inhibitors of the phosphatidylinositol 3-kinase/Akt and nitric oxide synthase/guanylyl cyclase pathways on the isometric contraction in rat aorta: a comparative study.
    López RM; Pérez T; Castillo C; Castillo EF
    Fundam Clin Pharmacol; 2011 Jun; 25(3):313-22. PubMed ID: 20584208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.